Boston Scientific (BSX) Other Non Operating Income (2009 - 2026)
Boston Scientific (BSX) posted quarterly Other Non Operating Income of -$118.0 million for Q2 2026, down 155.4% year-over-year from $213.0 million in Q2 2025, and down 178.15% on a QoQ basis from $151.0 million in Q1 2026.
Boston Scientific (BSX) Other Non Operating Income (2009 - 2026) Analysis & Trends
Boston Scientific has reported Other Non Operating Income for 18 years, with the latest figure at -$118.0 million in Q2 2026.
- Other Non Operating Income for Q2 2026 came in at -$118.0 million, down 155.4% year-over-year; the trailing twelve-month figure through Jun 2026 was -$461.0 million (down 694.83% YoY), and the FY2025 annual result was -$228.0 million, up 28.97% from the prior year.
- Other Non Operating Income slipped to -$118.0 million in Q2 2026, from $151.0 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $213.0 million in Q2 2025 and troughed at -$412.0 million in Q4 2022.
- A 5-year average of -$86.3 million and a median of -$66.0 million in 2024 frame the typical range for Other Non Operating Income.
- The widest annual swing landed in 2022, when Other Non Operating Income tumbled 1684.62%; it then jumped 313.0% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$412.0 million in 2022, then jumped by 32.04% to -$280.0 million in 2023, then soared by 67.86% to -$90.0 million in 2024, then sank by 326.67% to -$384.0 million in 2025, then surged by 69.27% to -$118.0 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$118.0 million in Q2 2026, $151.0 million in Q1 2026, and -$384.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -118.00 Mn |
| Mar 31, 2026 | 61.00 Mn |
| Dec 31, 2025 | -125.00 Mn |
| Sep 30, 2025 | -23.00 Mn |
| Jun 30, 2025 | 213.00 Mn |
| Mar 31, 2025 | -116.00 Mn |
| Dec 31, 2024 | -9.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | -100.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -15.00 Mn |
| Sep 30, 2023 | -18.00 Mn |
| Jun 30, 2023 | -18.00 Mn |
| Mar 31, 2023 | -43.00 Mn |
| Dec 31, 2022 | -412.00 Mn |
| Sep 30, 2022 | -51.00 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | -31.00 Mn |
| Dec 31, 2021 | 26.00 Mn |
| Sep 30, 2021 | 181.00 Mn |